Floatz logo

ACETIC

Central Sleep Apnea

Ottawa Heart Institute Research CorporationSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Central Sleep Apnea cohort.

Asset / SponsorPhaseRating
Acetazolamide
University of California, San Diego
Phase 2B

Same molecule, other indications

ACETIC is also rated in:

prostate cancerDormant
B
Indicative ·
56 / 100
View asset →
hepatocellular carcinomaDormant
CCC
Indicative ·
52 / 100
View asset →
cognitive disorderDormant
CCC
Indicative ·
51 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →